These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11081260)

  • 41. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solitary focus in the liver in a thyroid cancer patient after a whole body scan with 131 iodine.
    Pena Pardo FJ; Crespo de la Jara A; Fernández Morejón FJ; Sureda González M; Forteza Vila J; Brugarolas Masllorens A
    Rev Esp Med Nucl; 2007; 26(5):294-6. PubMed ID: 17910838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uncommon case of orbital metastasis secondary to papillary thyroid carcinoma.
    Boughattas S; Chatti K; Degdegui M; Bouslama Z; Elaouni C
    Thyroid; 2005 Nov; 15(11):1311-2. PubMed ID: 16356099
    [No Abstract]   [Full Text] [Related]  

  • 44. Early changes in fluorine-18-FDG uptake during radiotherapy.
    Hautzel H; Müller-Gärtner HW
    J Nucl Med; 1997 Sep; 38(9):1384-6. PubMed ID: 9293793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression.
    Smallridge RC; Castro MR; Morris JC; Young PR; Reynolds JC; Merino MJ; Sarlis NJ
    Thyroid; 2001 Aug; 11(8):795-804. PubMed ID: 11525275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
    Brandt-Mainz K; Müller SP; Sonnenschein W; Bockisch A
    J Nucl Med; 1998 Sep; 39(9):1536-41. PubMed ID: 9744338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Primary diagnosis of papillary thyroid carcinoma in the framework of staging of malignant melanoma with F-18 deoxyglucose using PET].
    Menzel C; Risse JH; Biersack HJ; Grünwald F
    Nuklearmedizin; 2001 Jun; 40(3):N23-4. PubMed ID: 11475082
    [No Abstract]   [Full Text] [Related]  

  • 48. [Papillary cancer of the thyroid: biological behaviour and therapeutic planning (author's transl)].
    Spreafico G; Colombo L; Puricelli G
    Radiol Med; 1978 Sep; 64(9):1005-20. PubMed ID: 749025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Thyroid carcinoma in children (author's transl)].
    Joppich I; Röher HD; Hecker WC; Knorr D; Daum R
    Klin Padiatr; 1980 Sep; 192(5):436-9. PubMed ID: 7192339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A proposition for the use of radioiodine in WDTC management.
    Bourgeois P
    J Nucl Med; 2009 Feb; 50(2):328-9; author reply 329-30. PubMed ID: 19164221
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance of lymph node metastases in differentiated thyroid carcinoma].
    Lerch H; Saur HB; Schober O
    Nuklearmedizin; 1995 Oct; 34(5):203-6. PubMed ID: 7479095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tc-99m hynic octreotide SPECT-MRI in brain metastasis of thyroid papillary-insular cancer.
    Gambini JP; Núñez M; Vila R; Noble J; Alonso O
    Clin Nucl Med; 2009 Dec; 34(12):920-1. PubMed ID: 20139835
    [No Abstract]   [Full Text] [Related]  

  • 55. Thallium-201 SPECT increases detectability of thyroid cancer metastases.
    Charkes ND; Vitti RA; Brooks K
    J Nucl Med; 1990 Feb; 31(2):147-53. PubMed ID: 2313353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different Tl-201 uptake patterns in papillary carcinoma of the thyroid and in a lymph node metastasis.
    Hardoff R; Baron E
    Clin Nucl Med; 1991 Sep; 16(9):688-9. PubMed ID: 1657487
    [No Abstract]   [Full Text] [Related]  

  • 57. Papillary thyroid cancer with metastasis to the skin.
    Junik R; Kłubo-Gwieździńska J; Zuchora Z; Zmyslowski W
    Clin Nucl Med; 2006 Jul; 31(7):435-6. PubMed ID: 16785820
    [No Abstract]   [Full Text] [Related]  

  • 58. Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report.
    Pacak K; Sweeney DC; Wartofsky L; Mark AS; Punja U; Azzam CJ; Burman KD
    Thyroid; 1998 Apr; 8(4):327-35. PubMed ID: 9588498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tumor redifferentiation in papillary thyroid carcinoma alter retinoic acid administration].
    Camacho Martí V; Estorch Cabrera M; Mena González E; Fuertes Manuel J; Hernández Fructuoso MA; Flotats Giralt A; Carrió Gasset I
    Rev Esp Med Nucl; 2004; 23(3):193-6. PubMed ID: 15153363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ; Verhagen C; Saris E; van den Broek WJ; Pieters GF; Corsten FH
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.